Related Experiment Videos
No butts about it: put the fire out by lighting up
1University of Chicago Medical Center, Illinois 60637, USA.
Inflammatory Bowel Diseases
|December 4, 1998
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Long-term efficacy and safety of ustekinumab for Crohn's disease through the second year of therapy.
Alimentary pharmacology & therapeutics·2018
Randomised clinical trial: efficacy, safety and dosage of adjunctive allopurinol in azathioprine/mercaptopurine nonresponders (AAA Study).
Alimentary pharmacology & therapeutics·2018
Long-term safety of adalimumab in clinical trials in adult patients with Crohn's disease or ulcerative colitis.
Alimentary pharmacology & therapeutics·2017
Randomised clinical trial: individualised vs. weight-based dosing of azathioprine in Crohn's disease.
Alimentary pharmacology & therapeutics·2013
Randomised clinical trial: the safety and tolerability of Trichuris suis ova in patients with Crohn's disease.
Alimentary pharmacology & therapeutics·2013
Confirmation of a susceptibility locus for Crohn's disease on chromosome 16.
Inflammatory bowel diseases·2013
Metabolomics predict treatment response to vedolizumab in pediatric IBD: results from the prospective VedoKids cohort study.
Inflammatory bowel diseases·2026
Clinical appraisal of handheld intestinal ultrasound in inflammatory bowel disease: Where are we now?
Inflammatory bowel diseases·2026
Reutilization of biologics for postoperative Crohn's disease recurrence prevention is effective.
Inflammatory bowel diseases·2026
FAPI-negative Papillary Renal Cell Carcinoma With Markedly FAPI-avid Sacral Insufficiency Fracture.
Clinical nuclear medicine·2026
Terrorist attacks on American fast-food restaurants: A counterterrorism medicine analysis.
American journal of disaster medicine·2026
γ-radiation reduces phosphorylated-tau in rhesus macaque brains: potential implications for Alzheimer's disease and other tauopathies.
Alzheimer's research & therapy·2026